Durch KI Einsatz in der Wirkstoffforschung und klinischen Studien,
Produktivität steigern, 'time to market' beschleunigen und Kosten senken.

September 01 - 03, 2025 | Palace Hotel Berlin, Germany

Agenda

Werden Sie Sponsor

Jetzt Buchen

Nikola Milosevic

Science Fellow Bayer AG

2. Konferenztag, 03. September 2025

1:50 PM Target discovery using GenAI, knowledge graphs and literature

-We have developed systems based on GenAI to rank and explain targets

-The system is based on literature, clinical trial documents, and knowledge graph

-Current state-of-the-art LLMs are able to analyze multi-modal data and provide comprehensive evaluation of the targets

-Pipeline can produce in few hours comprehensive summary of possible targets for a disease

Check out the incredible speaker line-up to see who will be joining Nikola.

Download The Latest Agenda

In Partnership With:

Connect With Us

Questions?

Tel: +49 30 52001534

E-mail: eq@iqpc.de

Imprint:
Company information according to § 5 Telemediengesetz
IQPC Gesellschaft für Management Konferenzen mbH
Address: Rosenstrasse 2, 10178 Berlin, Germany
Tel: 49 30 52 001 534
E-mail: info@iqpc.de
Registered at: Amtsgericht Charlottenburg, HRB 76720
VAT-Number: DE210454451
Management: Torben Haagh, Richard A. Worden, Michael R. Worden